NCT00637585View on ClinicalTrials.gov

Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

July 31, 2003

Conditions
Allergic Rhinitis
Interventions
DRUG

Fexofenadine

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00637585 - Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine | Biotech Hunter | Biotech Hunter